Abstract
Strategies that restore immune tolerance are attracting growing interest in their potential to advance the treatment of type 1 diabetes beyond lifelong insulin therapy. Dan Jones investigates.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice
Scientific Reports Open Access 13 October 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Retuning the immune system: the future of type 1 diabetes therapy?. Nat Rev Drug Discov 8, 600–601 (2009). https://doi.org/10.1038/nrd2956
Issue Date:
DOI: https://doi.org/10.1038/nrd2956
This article is cited by
-
TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice
Scientific Reports (2015)
